Iceland· IS-IS/1/13/083/01
Striverdi Respimat
A olodaterol product containing olodaterolum inn hýdróklóríð, registered in Iceland by Boehringer Ingelheim International GmbH*. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Olodaterol is registered in 14 of 19 countries.
Countries holding a registration under ATC R03AC19 (olodaterol), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Olodaterol · ATC R03AC19
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of olodaterol costs, country by country.
Normalised to the WHO defined daily dose (5 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Olodaterol · price per daily dose (5 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$1.64
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Olodaterolum INN hýdróklóríð
- Manufacturer
- Boehringer Ingelheim International GmbH*
- Country
- Iceland (IS)
- ATC code
- R03AC19
- ATC class
- Olodaterol
- Defined daily dose
- 5 mcg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean43681030 skammtar x1 pakkiISK 7203
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
386 interactions on record for olodaterol.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olodaterol · interactions on record
386 records
- 20 severe
- 365 moderate
- 1 minor
Most severe, free to view
- PindololC07AA03severe
- PropranololC07AA05severe
- TimololC07AA06severe
- SotalolC07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olodaterol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSTRIVERDI RESPIMATBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- United KingdomStriverdi Respimat 2.5micrograms/dose inhalation solution cartridge with deviceBoehringer Ingelheim Ltd
- SwitzerlandStriverdi Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)Boehringer Ingelheim (Schweiz) GmbH
- NetherlandsStriverdi Respimat 2,5 microgram, inhalatieoplossingBoehringer Ingelheim International GmbH
- FranceSTRIVERDI RESPIMAT 2,5 microgrammes/dose, solution à inhalerBOEHRINGER INGELHEIM INTERNATIONAL
- IrelandStriverdi Respimat 2.5 microgram inhalation solutionBoehringer Ingelheim International GmbH
- ItalySTRIVERDI RESPIMAT*soluz inal 60 erogazioni 2,5 mcg + 1 cartucciaBOEHRINGER INGELHEIM INT.GMBH
- NorwayStriverdi RespimatBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Striverdi Respimat
- Belgium · Striverdi Respimat
- Bulgaria · Стриверди Респимат
- Cyprus · Striverdi Respimat
- Czechia · Striverdi Respimat
- Germany · Striverdi Respimat
- Denmark · Striverdi Respimat
- Estonia · Striverdi Respimat
- Spain · Striverdi Respimat
- Finland · Striverdi Respimat
- France · Striverdi Respimat
- United Kingdom (Northern Ireland) · Striverdi Respimat
- Greece · Striverdi Respimat
- Hungary · Striverdi Respimat
- Ireland · Striverdi Respimat
- Italy · Striverdi Respimat
- Liechtenstein · Striverdi Respimat
- Lithuania · Striverdi Respimat
- Luxembourg · Striverdi Respimat
- Latvia · Striverdi Respimat
- Malta · Striverdi Respimat
- Netherlands · Striverdi Respimat
- Norway · Striverdi Respimat
- Poland · Striverdi Respimat
- Portugal · Striverdi Respimat
- Romania · Striverdi Respimat
- Sweden · Striverdi Respimat
- Slovenia · Striverdi Respimat
- Slovakia · Striverdi Respimat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7bc1b59-63da-4f9b-b4fb-0749e8cb91f6 GET /v1/drugs/f7bc1b59-63da-4f9b-b4fb-0749e8cb91f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innöndunarlausn",
"source": "lyfjastofnun",
"atc_raw": "R03AC19",
"marketed": false,
"strength": "2,5 míkróg",
"ma_number": "IS/1/13/083/01",
"substance": "Olodaterolum INN hýdróklóríð",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41557"
}See everything about olodaterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.